Literature DB >> 17908033

Early intervention in psychotic disorders: detection and treatment of the first episode and the critical early stages.

Patrick D McGorry1, Eóin Killackey, Alison R Yung.   

Abstract

The two main goals of early intervention in psychotic disorders are to reduce the period of time between the onset of psychosis and the commencement of effective treatment, and to provide consistent and comprehensive care during the critical early years of illness. Effective care during the critical early years involves proactive engagement and initiation of drug and psychosocial treatments, aiming for maximal symptomatic and functional recovery and the prevention of relapse. Over the past 15 years, an increasing number of specialised or streamed treatment delivery systems for early psychosis have been established around the world. There is now evidence that these services can reduce the duration of untreated psychosis and produce better symptomatic and functional recovery. In addition, they are more cost-effective than standard models of mental health care for these patients. Fully fledged, specialised early intervention services should be established, with full integration with local communities, as well as enhanced primary care systems focused on young people.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17908033     DOI: 10.5694/j.1326-5377.2007.tb01327.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  32 in total

Review 1.  What is the role of general practice in addressing youth mental health? A discussion paper.

Authors:  W Cullen; N Broderick; D Connolly; D Meagher
Journal:  Ir J Med Sci       Date:  2011-09-21       Impact factor: 1.568

2.  Model fidelity of assertive community treatment for clients with first-episode psychosis: a target group-specific application.

Authors:  M J M Verhaegh; I M B Bongers; H Kroon; H F L Garretsen
Journal:  Community Ment Health J       Date:  2008-10-16

Review 3.  Antipsychotic drugs for first-episode schizophrenia: a comparative review.

Authors:  Kayvon Salimi; L Fredrik Jarskog; Jeffrey A Lieberman
Journal:  CNS Drugs       Date:  2009-10       Impact factor: 5.749

Review 4.  The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.

Authors:  Sofia Brissos; Miguel Ruiz Veguilla; David Taylor; Vicent Balanzá-Martinez
Journal:  Ther Adv Psychopharmacol       Date:  2014-10

5.  Toward the early recognition of psychosis among Spanish-speaking adults on both sides of the U.S.-Mexico border.

Authors:  Rachel Nichole Casas; Edlin Gonzales; Eréndira Aldana-Aragón; María Del Carmen Lara-Muñoz; Alex Kopelowicz; Laura Andrews; Steven Regeser López
Journal:  Psychol Serv       Date:  2014-11

6.  Differences in duration of untreated psychosis for racial and ethnic minority groups with first-episode psychosis: an updated systematic review and meta-analysis.

Authors:  Nicole Schoer; Chen Wei Huang; Kelly K Anderson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-06-10       Impact factor: 4.328

7.  Factors Associated with Timely Physician Follow-up after a First Diagnosis of Psychotic Disorder.

Authors:  Kelly K Anderson; Paul Kurdyak
Journal:  Can J Psychiatry       Date:  2016-10-14       Impact factor: 4.356

8.  Strategies for effective recruitment of individuals at risk for developing psychosis.

Authors:  Isabel Domingues; Tracy Alderman; Kristin S Cadenhead
Journal:  Early Interv Psychiatry       Date:  2011-06-26       Impact factor: 2.732

9.  Patterns of health services use prior to a first diagnosis of psychosis: the importance of primary care.

Authors:  Kelly K Anderson; Rebecca Fuhrer; Willy Wynant; Michal Abrahamowicz; David L Buckeridge; Ashok Malla
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-02-21       Impact factor: 4.328

10.  Pupillometer-based neurofeedback cognitive training to improve processing speed and social functioning in individuals at clinical high risk for psychosis.

Authors:  Jimmy Choi; Cheryl M Corcoran; Joanna M Fiszdon; Michael Stevens; Daniel C Javitt; Melissa Deasy; Lawrence C Haber; Michael J Dewberry; Godfrey D Pearlson
Journal:  Psychiatr Rehabil J       Date:  2016-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.